Table 7.
Outcomes and interventions of 116 patients admitted to the ICU comparing COVID versus non-COVID patients
| Variable | Non-COVID (77) | COVID-19 (39) | p value |
|---|---|---|---|
| Multiorgan failure, n (%) | 32 (42) | 23 (59) | 0.08 |
| Renal Replacement Therapy, n (%) | 8 (10) | 9 (23) | 0.09 |
| Veno-venous ECMO, n (%) | 2 (3) | 10 (26) | 0.0003 |
| ICU Mortality, n (%) | 7 (9) | 5 (12.8) | 0.53 |
| Mechanical ventilation days, median (IQR) | 0.5 (0.3–1.8) | 25.8 (9.4–44.9) | <0.0001 |
| ICU length of stay days, median (IQR) | 2.2 (1.4–3.8) | 14.5 (5.6–34.6) | <0.0001 |
| Hospital length of stay days, median (IQR) | 7.1 (5.1–11.1) | 22.9 (10.7–42.2) | <0.0001 |
| 28 Day Mortality, n (%) | 8 (10) | 5 (12.8) | 0.75 |
| DVT or PE events, n (%) | 3 (4) | 10 (26) | 0.0009 |
ICU: intensive care unit, IQR: interquartile range, ECMO: extracorporeal membrane oxygenation, DVT: deep venous thrombosis, PE: pulmonary embolism.